Cite
HARVARD Citation
Cortellini, A. et al. (2020). Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events. European journal of cancer. pp. 17-26. [Online].